Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension.
Stephen L HauserRonald ZielmanAyan Das GuptaJing XiDee StonemanGoeril KarlssonDerrick RobertsonJeffrey A CohenLudwig KapposPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
ALITHIOS (NCT03650114): https://clinicaltrials.gov/ct2/show/NCT03650114.